Anterix Inc.
ATEX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $6 | $4 | $2 | $1 |
| % Growth | 43.9% | 118.4% | 77% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $6 | $4 | $2 | $1 |
| % Margin | 100% | 100% | 100% | 99.5% |
| R&D Expenses | $6 | $6 | $4 | $4 |
| G&A Expenses | $43 | $44 | $45 | $40 |
| SG&A Expenses | $49 | $50 | $51 | $44 |
| Sales & Mktg Exp. | $6 | $6 | $6 | $4 |
| Other Operating Expenses | -$37 | -$42 | -$37 | -$10 |
| Operating Expenses | $18 | $14 | $18 | $38 |
| Operating Income | -$12 | -$10 | -$16 | -$37 |
| % Margin | -194.2% | -241.5% | -857.8% | -3,399.3% |
| Other Income/Exp. Net | $2 | $3 | $1 | $0 |
| Pre-Tax Income | -$9 | -$8 | -$15 | -$37 |
| Tax Expense | $2 | $2 | $1 | $1 |
| Net Income | -$11 | -$9 | -$16 | -$38 |
| % Margin | -188.6% | -217.8% | -850.3% | -3,461.2% |
| EPS | -0.61 | -0.49 | -0.87 | -2.07 |
| % Growth | -24.5% | 43.7% | 58% | – |
| EPS Diluted | -0.61 | -0.49 | -0.87 | -2.07 |
| Weighted Avg Shares Out | 19 | 19 | 19 | 18 |
| Weighted Avg Shares Out Dil | 19 | 19 | 19 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$48 | -$52 | -$53 | -$47 |
| % Margin | -803.9% | -1,231.7% | -2,784.3% | -4,289.7% |